Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
Top Cited Papers
- 1 July 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 36 (1), 202-210
- https://doi.org/10.1053/jhep.2002.33993
Abstract
Recurrent hepatitis occurs in the majority of patients undergoing liver transplantation for hepatitis C virus (HCV) cirrhosis, with progression to cirrhosis in up to 30% after 5 years. Based on these data, a decrease in survival can be anticipated with prolonged follow-up. Furthermore, posttransplantation HCV-fibrosis progression has been shown in recent years to increase. Our aims were (1) to describe the natural history of HCV-infected recipients, particularly to determine whether survival has decreased in recent years; (2) to compare this outcome with that observed in non-HCV-infected cirrhosis controls; and (3) to determine the factors associated with disease severity and survival. Among 522 cirrhotic patients undergoing transplantation between 1991 and 2000, 283 (54%) were infected with HCV. Yearly biopsies were performed in these recipients and at 1 and 5 years in the remainder. With similar follow-up, the percentage of deaths in the HCV(+) group was significantly higher than in the HCV- group (37% vs. 22%, P <.001), and patient survival was lower (77%, 61%, 55% vs. 87%, 76%, 70% at 1, 5, and 7 years, respectively; P =.0001). Although survival has increased in the HCV- group in recent years, it has significantly decreased in HCV recipients (P <.0001). The main cause of death among the latter was decompensated graft cirrhosis (n = 23/105, 22%), whereas that of HCV- patients was infections (n = 10/52, 19%). Reasons for the recent worse outcome in HCV+ recipients include the increased donor age and stronger immunosuppression. In conclusion, patient survival is lower among HCV+ recipients than among HCV- ones and has been decreasing in recent years. The aging of donors is a major contributor to this worse outcome.This publication has 14 references indexed in Scilit:
- THE IMPACT OF DONOR AGE ON LIVER TRANSPLANTATION: INFLUENCE OF DONOR AGE ON EARLY LIVER FUNCTION AND ON SUBSEQUENT PATIENT AND GRAFT SURVIVALTransplantation, 2001
- Natural History of Clinically Compensated Hepatitis C Virus–Related Graft Cirrhosis After Liver TransplantationHepatology, 2000
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis CGastroenterology, 1999
- High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodesHepatology, 1999
- Predictors of patient and graft survival following liver transplantation for hepatitis CHepatology, 1998
- Liver transplantation in hepatitis C. A Spanish multi-centre experienceEuropean Journal of Gastroenterology & Hepatology, 1998
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationThe New England Journal of Medicine, 1996
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996
- Recurrent and acquired hepatitis C viral infection in liver transplant recipientsGastroenterology, 1992